This study is the first to report on the newly developed skin-electrode-based HE-2000 system. Our findings demonstrate that b-wave and flicker amplitudes were significantly lower, and implicit times of the a-and b-waves of the cone and flicker responses were longer, in non-dilated eyes compared to dilated eyes. However, the amplitudes of the b-waves of the cone response and flicker ERGs showed strong correlations between non-dilated and dilated eyes.
Skin electrodes tend to produce more noise than other electrode types, potentially hindering the accurate measurement of a-waves. This could be due to electrical interference, which reduces the sensitivity of the recordings, particularly for low-amplitude responses like the a-wave. This limitation should be considered when interpreting results from the HE-2000 system.
A previous study investigated the effect of a non-dilated pupil on the photopic and scotopic luminance response function 23; they confirmed prolonged a- and b-wave implicit times in non-dilated eyes than in dilated ones. These longer implicit times were normalized after increasing the background luminance from 25 cd/m2 to 80 cd/m2. Therefore, it might be feasible for the HE-2000 system to record implicit times in non-dilated pupils closer to those in dilated pupils by increasing background illumination. However, the current HE-2000 system does not allow adjustments to the default background illumination of 30 cd/m2, precluding further assessment. Future iterations of the system should incorporate an adjustable interface for background illumination.
Normalizing the amplitude in non-dilated eyes presents a greater challenge than normalizing implicit time. A previous report indicated a rightward shift of the photopic luminance-response function, with the highest amplitude achieved at 3.9 cd·s/m2 in dilated eyes but 10.6 cd·s/m2 in non-dilated ones 23. This nearly three-fold increase in luminance required for maximum response in non-dilated eyes may justify the HE-2000’s default setting of 10 cd·s/m2 for non-mydriatic mode as opposed to the 3 cd·s/m2 used in mydriatic mode. However, the same study reported that even with sufficient luminance, non-dilated eyes yielded maximum amplitudes up to only 14% lower than dilated ones 23. This difference may be attributed to the smaller pupillary apertures in non-dilated eyes, which limit the amount of light reaching peripheral cone photoreceptors compared to dilated pupils. Notably, the study reported that the maximum response could not be normalized, even with changing the background luminance 23. This suggests that non-dilated eyes require a different reference range of amplitudes than dilated ones.
A previous study that employed the RETeval system in eyes with cataract reported no significant difference in the flicker ERG amplitudes and implicit times between dilated and non-dilated eyes 24. In contrast, our study employing the HE-2000 system observed lower flicker ERG amplitudes and longer implicit times in non-dilated eyes compared to dilated ones. This discrepancy maybe attributed to be the inability of the HE-2000 system to deliver constant retinal illuminance. The RETeval system can deliver constant retinal illuminance (Td·s), whereas the HE-2000 system can only deliver constant luminance (cd·s/m2); this difference may influence the flicker ERG results, as a flash stimulus of 10 cd·s/m2 in non-dilated eyes may be insufficient to produce retinal illuminance equivalent to that in dilated eyes.
A previous study investigated the differences between constant luminance and constant retinal illuminance in flicker ERGs 25, demonstrating that constant retinal illuminance results in less intra-subject variability 25. This suggests that the RETeval system, by delivering constant retinal luminance, reduces variations in retinal stimulation caused by pupillary changes and provides narrower reference ranges compared to the HE-2000 system. Thus, compared to the RETeval, the HE-2000 system has the disadvantage of being unable to deliver constant retinal illuminance; however, the HE-2000 offers the advantage of simultaneous binocular measurements.
Sugawara et al. highlighted the inability of the RETeval system to perform simultaneous binocular measurements as a disadvantage 26. In their study, they measured flicker ERGs twice in the same subject across two sessions using RETeval; the first measurement was taken in the right eye followed by the left eye, and the second measurement was taken in the left eye followed by the right eye. They observed a prolongation of implicit times in the second session compared to the first, indicating potential measurement inconsistencies unless protocols were established in advance. The HE-2000 system, with its simultaneous binocular measurement capability, eliminates this potential variability. However, achieving simultaneous real-time pupil monitoring in both eyes presents technical challenges 26. Ultimately, the RETeval system's constant retinal illumination and the HE-2000 system's simultaneous binocular measurement capability are considered a trade-off, making it difficult to definitively assess their overall superiority or inferiority. Further studies directly comparing the clinical usefulness of these two systems are necessary.
Another factor that warrants consideration is the use of skin electrodes. While less invasive and easier to apply than corneal electrodes, skin electrodes inherently introduce higher levels of noise. This may have contributed to the relatively low amplitude of the a-wave in non-mydriatic eyes, as the a-wave, representing a smaller, earlier response, may be more susceptible to noise interference, hindering their detection. Although the HE-2000 incorporates a subtraction system to reduce noise, it may not have been sufficient to mitigate this issue entirely, particularly in non-mydriatic recordings, where the signal-to-noise ratio may already be compromised.
Despite these limitations, our study demonstrated a strong correlation between the amplitude and implicit time of the b-wave and flicker ERG responses in both dilated and non-dilated eyes. This suggests that clinically relevant measurements can be obtained even from non-mydriatic eyes provided that appropriate correction factors or formulas are applied. Such corrections could enable safer and more practical ERG recordings, especially in situations where pupil dilation is not feasible or advisable.
In addition to the aforementioned considerations, this study had several limitations. First, pupil diameter was not measured during the ERG recordings, precluding a comprehensive assessment of the impact of pupillary constriction on photopic ERG responses. Future studies should incorporate pupil monitoring to better understand the influence of the natural pupil size on the recorded signals. Second, the HE-2000 system’s continuous measurement mode, employed in this study, deviates from ISCEV standards. Consequently, the findings may not be directly comparable to those of other ERG studies adhering to standard protocols. Validation of this continuous mode is necessary to establish its clinical relevance. Third, we focused exclusively on photopic ERG recordings and did not evaluate scotopic ERG responses. Further research is required to assess the system's performance under scotopic conditions, particularly in non-dilated eyes. Finally, the relatively small sample size limits the generalizability of the results. Further studies with larger cohorts are needed to validate these findings.
In conclusion, this study demonstrated that the HE-2000 system can effectively measure photopic ERG responses in both dilated and non-dilated eyes, although amplitudes and implicit times differ between the two conditions. Despite these differences, the strong correlation between b-wave and flicker ERG responses in dilated and non-dilated eyes suggests that clinically useful data can still be obtained without pupillary dilation, particularly with the application of appropriate correction formulas. Further studies are necessary to optimize the system’s performance under non-mydriatic conditions and further explore its potential utility across diverse patient populations.